Literature DB >> 12484630

Molecular spectrum of alpha-thalassemia in Tunisia: epidemiology and detection at birth.

Amine Zorai1, Cornelis L Harteveld, Achech Bakir, Peter Van Delft, Abdelaziz Falfoul, Koussay Dellagi, Salem Abbes, Piero C Giordano.   

Abstract

We present the characterization of the molecular spectrum and frequency data of alpha-thal (thal) defects in Tunisia, and an evaluation of the efficacy and limitations of Hb Bart's (gamma4) measurement for the screening of alpha-thal at birth. Cord blood samples were collected from two different areas: the northeast of the country, an area where Hb H (beta4) disease frequently occurs, and Tunis, the capital city, representative of the average Tunisian population. From the first group, 110 samples with Hb Bart's and/or microcytosis at birth were selected from 1270 randomly collected samples. Two additional population samples, one from the same northeastern region (n = 90), the other from Tunis (n = 104) were collected randomly. Nine common deletional alpha-thal defects and nondeletional mutations were screened. In the northeastern samples, selected for the presence of Hb Bart's and microcytosis, the -alpha3.7 deletion was the most common defect (4.5% allele frequency) followed by a polyadenylation (poly A) signal mutation (1.8%), the five nucleotide (nt) deletion and the -alpha4.2 deletion (both 0.9%). The African polymorphism (G-->TCGGCCC at position 7238 and T-->G at 7174) was found with an allele frequency of 11% in the selected northeastern samples. In the random population samples, the overall alpha-thal allele frequency was 4% in the northeast region, against 2% in the average Tunisian population. The +14 (G-->C) polymorphism in the 5'UTR (untranslated region) of the alpha2 gene and the African polymorphism in the second intron of the same gene, were found in 3.5% of the alleles. No alpha0-thal alleles were found among the 304 blood samples studied at the DNA level during this survey.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12484630     DOI: 10.1081/hem-120016372

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  5 in total

1.  The epidemiology of abnormal hemoglobins in Mediterranean high-level athletes.

Authors:  Imed Touhami; Slaheddine Fattoum; Amina Bibi; Hajer Siala; Taieb Messaoud; Donia Koubaa; Rafik Mankai; Zakia Bartagi; Daniel Le Gallais
Journal:  Eur J Appl Physiol       Date:  2009-12-16       Impact factor: 3.078

2.  Epidemiological profile of common haemoglobinopathies in Arab countries.

Authors:  Hanan A Hamamy; Nasir A S Al-Allawi
Journal:  J Community Genet       Date:  2012-12-08

3.  alpha-Thalassaemia in Tunisia: some epidemiological and molecular data.

Authors:  H Siala; F Ouali; T Messaoud; A Bibi; S Fattoum
Journal:  J Genet       Date:  2008-12       Impact factor: 1.166

Review 4.  Alpha-thalassaemia.

Authors:  Cornelis L Harteveld; Douglas R Higgs
Journal:  Orphanet J Rare Dis       Date:  2010-05-28       Impact factor: 4.123

5.  Alpha chain hemoglobins with electrophoretic mobility similar to that of hemoglobin S in a newborn screening program.

Authors:  Marcilene Rezende Silva; Shimene Mascarenhas Sendin; Isabela Couto de Oliveira Araujo; Fernanda Silva Pimentel; Marcos Borato Viana
Journal:  Rev Bras Hematol Hemoter       Date:  2013
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.